Dapagliflozin EP Impurity B (Free Base)
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

3093141-55-7Dapagliflozin EP Impurity B (Free Base)

● In Stock

Catalogue No.:VE0011051
CAS No.:3093141-55-7
Mol. Formula:C23H29ClO6
Mol. Weight:436.9 g/mol

Order Online

UNIT PRICE QTY STATUS ACTION
100 mg $522.00
● In Stock
We accept Credit Card Icons

Additional information on CAS 3093141-55-7

Parent drug

Dapagliflozin

IUPAC Name

(1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxy-3- ethylphenyl)methyl]phenyl]-D-glucitol

Pharmacopeial Synonyms

Ethyl Dapagliflozin

Synonyms

Dapagliflozin Impurity 27

Smiles

O[C@H]1[C@H](C2=CC=C(Cl)C(CC3=CC=C(OCC)C(CC)=C3)=C2)O[C@H](CO)[C@@H](O)[C@@H]1O

InChI

InChI=1S/C23H29ClO6/c1-3-14-9-13(5-8-18(14)29-4-2)10-16-11-15(6-7-17(16)24)23-22(28)21(27)20(26)19(12-25)30-23/h5-9,11,19-23,25-28H,3-4,10,12H2,1-2H3/t19-,20-,21+,22-,23+/m1/s1

Description

Dapagliflozin EP Impurity B, also designated Dapagliflozin Impurity 27 and Ethyl Dapagliflozin, is a structurally related ether analog of the SGLT2 inhibitor dapagliflozin, corresponding to alkylation at the phenolic oxygen by an ethyl substituent. This process-related impurity, CAS 3093141-55-7, has molecular formula C23H29ClO6 and molecular weight 436.9 g/mol. Its presence is typically associated with synthetic side-reactions or incomplete dealkylation control during route development. Because of close chromatographic and mass spectrometric similarity to the parent drug, characterization commonly requires LC-MS/MS, high-resolution mass spectrometry, and orthogonal HPLC separations for definitive assignment and quantification.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url